Pancreatic Cancer Research

ResearcherShizuoka Cancer CenterActive in the last 2 years

Hiroyuki Ono

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-8215-1720; OpenAlex author ID A5101705883. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 9

  1. Impact of tumor necrosis on comprehensive genomic profiling success in pancreatic cancer: a retrospective study. Last author DOI 10.1093/jjco/hyaf156↗
  2. Genetic medicine of familial and hereditary pancreatic cancer: Recent update in the era of precision cancer medicine. Last author DOI 10.1002/jhbp.12112↗
  3. Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. Co-author DOI 10.1038/s10038-022-01097-y↗
  4. Comparing the 14-mm uncovered and 10-mm covered metal stents in patients with distal biliary obstruction caused by unresectable pancreatic cancer: a multicente… Co-author DOI 10.1007/s00464-021-08342-z↗
  5. Comparison of five-phase computed tomography images of type 1 autoimmune pancreatitis and pancreatic cancer: Emphasis on cases with atypical images. Last author DOI 10.1016/j.pan.2021.01.016↗
  6. Multiple Carcinomas and Intraepithelial Neoplasms in a Case of Familial Pancreatic Cancer: Rapid Morphological Changes in the Pancreatic Cyst and Pathological … Last author DOI 10.2169/internalmedicine.3882-19↗
  7. Detecting Early Pancreatic Cancer: Current Problems and Future Prospects. Last author DOI 10.5009/gnl18491↗
  8. Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers. Last author DOI 10.3390/diagnostics9040169↗
  9. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. Co-author DOI 10.1097/mpa.0b013e3182156e1b↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroyuki Matsubayashi · 8 shared papers, 2011–2025 · strength 1.20
  2. Hirotoshi Ishiwatari · 7 shared papers, 2019–2026 · strength 1.00
  3. Yoshimi Kiyozumi · 4 shared papers, 2019–2025 · strength 0.79
  4. Katsuhiko Uesaka · 4 shared papers, 2011–2020 · strength 0.39
  5. Tatsunori Satoh · 3 shared papers, 2020–2022 · strength 0.35
  6. Masataka Kikuyama · 2 shared papers, 2019–2022 · strength 0.26
  7. Teiichi Sugiura · 2 shared papers, 2021–2023 · strength 0.25
  8. Junya Sato · 2 shared papers, 2020–2022 · strength 0.25
  9. Hiroki Sakamoto · 1 shared paper, 2026 · strength 0.24
  10. Tomoko Norose · 1 shared paper, 2026 · strength 0.24
  11. Takuya Doi · 1 shared paper, 2026 · strength 0.24
  12. Kentaro Yamazaki · 2 shared papers, 2011–2023 · strength 0.17
  13. Takeshi Kawakami · 1 shared paper, 2023 · strength 0.14
  14. Fumitaka Niiya · 1 shared paper, 2023 · strength 0.14
  15. Hirofumi Yasui · 1 shared paper, 2023 · strength 0.14
  16. Akiko Todaka · 1 shared paper, 2023 · strength 0.14
  17. Naofumi Shirane · 1 shared paper, 2022 · strength 0.14
  18. Shuzo Terada · 1 shared paper, 2022 · strength 0.14
  19. Shinya Kawaguchi · 1 shared paper, 2022 · strength 0.14
  20. Kenji Notohara · 1 shared paper, 2020 · strength 0.11
  21. Ryo Ashida · 1 shared paper, 2020 · strength 0.11
  22. Ralph H. Hruban · 1 shared paper, 2020 · strength 0.11
  23. Keita P. Mori · 1 shared paper, 2021 · strength 0.10
  24. Hideyuki Kanemoto · 1 shared paper, 2011 · strength 0.02
  25. Atsuyuki Maeda · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.